New “Nervenheilkunde” Article Explores AI in Psychiatry: Challenges and Emerging Opportunities
New “Nervenheilkunde” Article Explores AI in Psychiatry: Challenges and Emerging Opportunities
A new article in the latest issue of Nervenheilkunde—co‑authored by Kerstin Ritter—takes a close look at the evolving role of artificial intelligence in psychiatry. As one of Germany’s leading journals at the intersection of neurology, psychiatry, and psychotherapy, Nervenheilkunde provides primary care physicians and specialists with up‑to‑date scientific insights and practical guidance for improving patient care.
The article outlines why AI, despite its strong performance in many areas of medicine, has so far had limited impact in psychiatry. Key challenges include the high heterogeneity of psychiatric disorders, the lack of reliable individual biomarkers, and variability in clinical diagnoses. At the same time, the authors highlight promising developments: pretrained multimodal models that integrate diverse data sources, emerging digital biomarkers from speech and behavior, and AI‑based systems that may support aspects of care.
The piece also addresses persistent obstacles such as fragmented data infrastructures, algorithmic bias, and open questions around transparency, regulation, and ethics. Ultimately, the authors argue that the clinical value of AI in psychiatry will depend on identifying contexts where robust, interpretable, and generalizable models can meaningfully support diagnosis, prognosis, and personalized treatment.
The article “AI in Psychiatry” is part of the series in issue 1.2/2026, “The New Berlin Psychiatry Center” (Nervenheilkunde 2026; 45: 1–2)
https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-2727-9015
DOI: 10.1055/a-2727-9015
Share article
Author
Prof. Dr. Kerstin Ritter
Prof. Dr. Kerstin Ritter is a Full Professor of Machine Learning for Clinical Neuroscience at the University of Tübingen and is a Director at the Hertie Institute for AI in Brain Health. She is PI in the Excellence Cluster “Machine Learning – New Perspectives for Science” and the Tübingen AI Center as well as multiple interdisciplinary research consortia focusing on innovative methods at the intersection of machine learning, statistics and medical applications in neurology and psychiatry. Her research focuses on using advanced AI methods to assess brain health through diverse data types, including neuroimaging, clinical, genetic, and behavioral data. Her contributions to the field have been recognized with awards such as the NARSAD Young Investigator Grant and the Deutsche Multiple Sklerose Gesellschaft Research Prize.